[Comparison of the effects of fenofibrate administered in doses of 3 x 100mg and 1 x 250mg per day in patients with type IIA, IIB and IV hyperlipoproteinemias]

Acta Med Iugosl. 1988;42(5):353-62.
[Article in Croatian]
No abstract available

Publication types

  • Comparative Study
  • English Abstract

MeSH terms

  • Adult
  • Aged
  • Female
  • Fenofibrate / administration & dosage*
  • Fenofibrate / therapeutic use
  • Humans
  • Hyperlipoproteinemia Type II / blood
  • Hyperlipoproteinemia Type II / drug therapy
  • Hyperlipoproteinemia Type IV / blood
  • Hyperlipoproteinemia Type IV / drug therapy
  • Hyperlipoproteinemias / blood
  • Hyperlipoproteinemias / drug therapy*
  • Male
  • Middle Aged
  • Propionates / administration & dosage*

Substances

  • Propionates
  • Fenofibrate